BTAIVSVTGN• 12 Months (Normalized)
BTAI vs VTGN (BioXcel Therapeutics Inc. vs Vistagen Therapeutics Inc.)
Showing Closing Date Range from Sep 29, 2025 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
-98.65%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
VTGN Performance $0.37
+%
Vistagen Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin VTGN LEADS
-98.65 pts
VTGN outperforming by 98.65 percentage points
BTAIVTGN
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI VTGN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(249 dates)
| Date | BTAI Price | BTAI Gain (%) | VTGN Price | VTGN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $0.04 | -98.65% | $- | - | |
| Sep 23, 2026 | $0.05 | -98.28% | $0.37 | -89.55% | -8.73% |
| Sep 22, 2026 | $0.04 | -98.30% | $0.25 | -92.94% | -5.36% |
| Sep 21, 2026 | $0.06 | -97.65% | $0.23 | -93.50% | -4.15% |
| Sep 18, 2026 | $0.06 | -97.79% | $0.24 | -93.22% | -4.57% |
| Sep 17, 2026 | $0.08 | -97.13% | $0.23 | -93.50% | -3.63% |
| Sep 16, 2026 | $0.07 | -97.45% | $0.23 | -93.50% | -3.95% |
| Sep 15, 2026 | $0.04 | -98.29% | $0.24 | -93.22% | -5.07% |
| Sep 14, 2026 | $0.05 | -98.28% | $0.24 | -93.13% | -5.15% |
| Sep 11, 2026 | $0.05 | -98.05% | $0.24 | -93.22% | -4.83% |
| Sep 10, 2026 | $0.05 | -98.09% | $0.24 | -93.22% | -4.87% |
| Sep 09, 2026 | $0.05 | -98.21% | $0.24 | -93.22% | -4.99% |
| Sep 08, 2026 | $0.04 | -98.36% | $0.24 | -93.22% | -5.14% |
| Sep 04, 2026 | $0.07 | -97.18% | $0.24 | -93.22% | -3.96% |
| Sep 03, 2026 | $0.12 | -95.50% | $0.25 | -92.94% | -2.56% |
Page 1 of 17